Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

MULTIPLEX PCR BASED URINARY TRACT INFECTION (UTI) ANALYSIS COMPARED TO TRADITIONAL URINE CULTURE IN IDENTIFYING SIGNIFICANT PATHOGENS IN SYMPTOMATIC PATIENTS.

Wojno KJ, Baunoch D, Luke N, Opel M, Korman H, Kelly C, Jafri SMA, Keating P, Hazelton D, Hindu S, Makhloouf B, Wenzler D, Sabry M, Burks F, Penaranda M, Smith DE, Korman A, Sirls L.

Urology. 2019 Nov 9. pii: S0090-4295(19)30963-X. doi: 10.1016/j.urology.2019.10.018. [Epub ahead of print]

PMID:
31715272
2.

Galectin-1-driven T cell exclusion in the tumor endothelium promotes immunotherapy resistance.

Nambiar DK, Aguilera T, Cao H, Kwok S, Kong C, Bloomstein J, Wang Z, Rangan VS, Jiang D, von Eyben R, Liang R, Agarwal S, Colevas AD, Korman A, Allen CT, Uppaluri R, Koong AC, Giaccia A, Le QT.

J Clin Invest. 2019 Nov 11. pii: 129025. doi: 10.1172/JCI129025. [Epub ahead of print]

3.

VISTA is an acidic pH-selective ligand for PSGL-1.

Johnston RJ, Su LJ, Pinckney J, Critton D, Boyer E, Krishnakumar A, Corbett M, Rankin AL, Dibella R, Campbell L, Martin GH, Lemar H, Cayton T, Huang RY, Deng X, Nayeem A, Chen H, Ergel B, Rizzo JM, Yamniuk AP, Dutta S, Ngo J, Shorts AO, Ramakrishnan R, Kozhich A, Holloway J, Fang H, Wang YK, Yang Z, Thiam K, Rakestraw G, Rajpal A, Sheppard P, Quigley M, Bahjat KS, Korman AJ.

Nature. 2019 Oct;574(7779):565-570. doi: 10.1038/s41586-019-1674-5. Epub 2019 Oct 23.

PMID:
31645726
4.

A survey-based study of diagnostic and treatment concordance in standardized cases of cellulitis and pseudocellulitis via teledermatology.

Korman AM, Kroshinsky D, Raff AB, Mostaghimi A, Micheletti RG, Rosenbach M, Kaffenberger BH; Society of Dermatology Hospitalists Scientific Task Force on Cellulitis.

J Am Acad Dermatol. 2019 Oct 15. pii: S0190-9622(19)32911-1. doi: 10.1016/j.jaad.2019.09.084. [Epub ahead of print] No abstract available.

PMID:
31626887
5.

An Integrative Approach to Inform Optimal Administration of OX40 Agonist Antibodies in Patients with Advanced Solid Tumors.

Wang R, Gao C, Raymond M, Dito G, Kabbabe D, Shao X, Hilt E, Sun Y, Pak I, Gutierrez M, Melero I, Spreafico A, Carvajal RD, Ong M, Olszanski AJ, Milburn C, Thudium K, Yang Z, Feng Y, Fracasso PM, Korman AJ, Aanur P, Huang SA, Quigley M.

Clin Cancer Res. 2019 Nov 15;25(22):6709-6720. doi: 10.1158/1078-0432.CCR-19-0526. Epub 2019 Oct 1.

PMID:
31573956
6.

Blood-brain barrier permeable nano immunoconjugates induce local immune responses for glioma therapy.

Galstyan A, Markman JL, Shatalova ES, Chiechi A, Korman AJ, Patil R, Klymyshyn D, Tourtellotte WG, Israel LL, Braubach O, Ljubimov VA, Mashouf LA, Ramesh A, Grodzinski ZB, Penichet ML, Black KL, Holler E, Sun T, Ding H, Ljubimov AV, Ljubimova JY.

Nat Commun. 2019 Aug 28;10(1):3850. doi: 10.1038/s41467-019-11719-3.

7.

Can the Internet Replace Face-to-Face Teaching? A Medical Student's Perspective.

Korman AA, Tannen AJ, Mahgerefteh MY.

Acad Med. 2019 Apr;94(4):457. doi: 10.1097/ACM.0000000000002576. No abstract available.

PMID:
30913074
8.

CD96 Is an Immune Checkpoint That Regulates CD8+ T-cell Antitumor Function.

Mittal D, Lepletier A, Madore J, Aguilera AR, Stannard K, Blake SJ, Whitehall VLJ, Liu C, Bettington ML, Takeda K, Long GV, Scolyer RA, Lan R, Siemers N, Korman A, Teng MWL, Johnston RJ, Dougall WC, Smyth MJ.

Cancer Immunol Res. 2019 Apr;7(4):559-571. doi: 10.1158/2326-6066.CIR-18-0637. Epub 2019 Mar 20.

9.

New epitopes in ovalbumin provide insights for cancer neoepitopes.

Karandikar SH, Sidney J, Sette A, Selby MJ, Korman AJ, Srivastava PK.

JCI Insight. 2019 Mar 14;5. pii: 127882. doi: 10.1172/jci.insight.127882.

10.

Targeting DDR2 enhances tumor response to anti-PD-1 immunotherapy.

Tu MM, Lee FYF, Jones RT, Kimball AK, Saravia E, Graziano RF, Coleman B, Menard K, Yan J, Michaud E, Chang H, Abdel-Hafiz HA, Rozhok AI, Duex JE, Agarwal N, Chauca-Diaz A, Johnson LK, Ng TL, Cambier JC, Clambey ET, Costello JC, Korman AJ, Theodorescu D.

Sci Adv. 2019 Feb 20;5(2):eaav2437. doi: 10.1126/sciadv.aav2437. eCollection 2019 Feb.

11.

Change as an opportunity - Collaborative research in a fluctuating global landscape.

Mahgerefteh MY, Math NV, Korman AA.

J Adv Med Educ Prof. 2019 Jan;7(1):47-48. No abstract available.

12.

Biological effects of mixed-ion beams. Part 2: The relative biological effectiveness of CHO-K1 cells irradiated by mixed- and single-ion beams.

Czub J, Banaś D, Braziewicz J, Buraczewska I, Jaskóła M, Kaźmierczak U, Korman A, Lankoff A, Lisowska H, Szefliński Z, Wojewódzka M, Wójcik A.

Appl Radiat Isot. 2019 Aug;150:192-198. doi: 10.1016/j.apradiso.2018.12.001. Epub 2018 Dec 5.

PMID:
30553541
13.

Acrodermatitis Continua of Hallopeau.

Korman AM, Rzepka PV, Sopkovich JA.

JAMA Dermatol. 2018 Nov 1;154(11):1346. doi: 10.1001/jamadermatol.2018.3350. No abstract available.

PMID:
30285064
14.

Expression of LAG-3 and efficacy of combination treatment with anti-LAG-3 and anti-PD-1 monoclonal antibodies in glioblastoma.

Harris-Bookman S, Mathios D, Martin AM, Xia Y, Kim E, Xu H, Belcaid Z, Polanczyk M, Barberi T, Theodros D, Kim J, Taube JM, Burger PC, Selby M, Taitt C, Korman A, Ye X, Drake CG, Brem H, Pardoll DM, Lim M.

Int J Cancer. 2018 Dec 15;143(12):3201-3208. doi: 10.1002/ijc.31661. Epub 2018 Sep 24.

PMID:
30248181
15.

Urticaria: A comprehensive review: Treatment of chronic urticaria, special populations, and disease outcomes.

Antia C, Baquerizo K, Korman A, Alikhan A, Bernstein JA.

J Am Acad Dermatol. 2018 Oct;79(4):617-633. doi: 10.1016/j.jaad.2018.01.023. Review.

PMID:
30241624
16.

Urticaria: A comprehensive review: Epidemiology, diagnosis, and work-up.

Antia C, Baquerizo K, Korman A, Bernstein JA, Alikhan A.

J Am Acad Dermatol. 2018 Oct;79(4):599-614. doi: 10.1016/j.jaad.2018.01.020. Review.

PMID:
30241623
17.

TIGIT and PD-1 dual checkpoint blockade enhances antitumor immunity and survival in GBM.

Hung AL, Maxwell R, Theodros D, Belcaid Z, Mathios D, Luksik AS, Kim E, Wu A, Xia Y, Garzon-Muvdi T, Jackson C, Ye X, Tyler B, Selby M, Korman A, Barnhart B, Park SM, Youn JI, Chowdhury T, Park CK, Brem H, Pardoll DM, Lim M.

Oncoimmunology. 2018 May 24;7(8):e1466769. doi: 10.1080/2162402X.2018.1466769. eCollection 2018.

18.

Applying to dermatology residency: An ethical approach to an inherently unethical process.

Korman AM, Grant-Kels JM.

Int J Womens Dermatol. 2018 May 26;4(3):176-178. doi: 10.1016/j.ijwd.2018.01.001. eCollection 2018 Sep. No abstract available.

19.

Subclinical granulomas in benign skin lesions heralding the onset of BRAF and MEK inhibitor-associated granulomatous dermatitis in a patient with metastatic melanoma.

Korman AM, Nisar MS, Somach SC.

JAAD Case Rep. 2018 Aug 16;4(7):722-724. doi: 10.1016/j.jdcr.2018.05.011. eCollection 2018 Aug. No abstract available.

20.

CD226 opposes TIGIT to disrupt Tregs in melanoma.

Fourcade J, Sun Z, Chauvin JM, Ka M, Davar D, Pagliano O, Wang H, Saada S, Menna C, Amin R, Sander C, Kirkwood JM, Korman AJ, Zarour HM.

JCI Insight. 2018 Jul 26;3(14). pii: 121157. doi: 10.1172/jci.insight.121157. eCollection 2018 Jul 26.

21.

Elective Nodal Irradiation Attenuates the Combinatorial Efficacy of Stereotactic Radiation Therapy and Immunotherapy.

Marciscano AE, Ghasemzadeh A, Nirschl TR, Theodros D, Kochel CM, Francica BJ, Muroyama Y, Anders RA, Sharabi AB, Velarde E, Mao W, Chaudhary KR, Chaimowitz MG, Wong J, Selby MJ, Thudium KB, Korman AJ, Ulmert D, Thorek DLJ, DeWeese TL, Drake CG.

Clin Cancer Res. 2018 Oct 15;24(20):5058-5071. doi: 10.1158/1078-0432.CCR-17-3427. Epub 2018 Jun 13.

22.

Biological effects of mixed-ion beams. Part 1: Effect of irradiation of the CHO-K1 cells with a mixed-ion beam containing the carbon and oxygen ions.

Czub J, Banaś D, Braziewicz J, Buraczewska I, Jaskóła M, Kaźmierczak U, Korman A, Lankoff A, Lisowska H, Szefliński Z, Wojewódzka M, Wójcik A.

Appl Radiat Isot. 2018 Sep;139:304-309. doi: 10.1016/j.apradiso.2018.05.028. Epub 2018 May 30.

PMID:
29883949
23.

An Unusual Cause of Rectal Bleeding in a 34-Year-Old Male.

Kohli M, Charilaou P, Enjamuri D, Rosenthal M, Korman A.

Am J Gastroenterol. 2018 Jul;113(7):1055-1056. doi: 10.1038/s41395-018-0096-6. Epub 2018 Jun 8. No abstract available.

PMID:
29880967
24.

An open-label, multiple ascending dose study of the anti-CTLA-4 antibody ipilimumab in viremic HIV patients.

Colston E, Grasela D, Gardiner D, Bucy RP, Vakkalagadda B, Korman AJ, Lowy I.

PLoS One. 2018 Jun 7;13(6):e0198158. doi: 10.1371/journal.pone.0198158. eCollection 2018.

25.

Limits on reliable information flows through stochastic populations.

Boczkowski L, Natale E, Feinerman O, Korman A.

PLoS Comput Biol. 2018 Jun 6;14(6):e1006195. doi: 10.1371/journal.pcbi.1006195. eCollection 2018 Jun. Erratum in: PLoS Comput Biol. 2018 Aug 9;14(8):e1006404.

26.

The Hfq chaperone helps the ribosome mature.

Sharma IM, Korman A, Woodson SA.

EMBO J. 2018 Jun 1;37(11). pii: e99616. doi: 10.15252/embj.201899616. Epub 2018 May 15. No abstract available.

27.

Tumor-Specific Inhibition of In Situ Vaccination by Distant Untreated Tumor Sites.

Morris ZS, Guy EI, Werner LR, Carlson PM, Heinze CM, Kler JS, Busche SM, Jaquish AA, Sriramaneni RN, Carmichael LL, Loibner H, Gillies SD, Korman AJ, Erbe AK, Hank JA, Rakhmilevich AL, Harari PM, Sondel PM.

Cancer Immunol Res. 2018 Jul;6(7):825-834. doi: 10.1158/2326-6066.CIR-17-0353. Epub 2018 May 10.

28.

Complimentary mechanisms of dual checkpoint blockade expand unique T-cell repertoires and activate adaptive anti-tumor immunity in triple-negative breast tumors.

Crosby EJ, Wei J, Yang XY, Lei G, Wang T, Liu CX, Agarwal P, Korman AJ, Morse MA, Gouin K, Knott SRV, Lyerly HK, Hartman ZC.

Oncoimmunology. 2018 Jan 19;7(5):e1421891. doi: 10.1080/2162402X.2017.1421891. eCollection 2018.

29.

Stem-cell therapy in ST-segment elevation myocardial infarction with reduced ejection fraction: A multicenter, double-blind randomized trial.

Nicolau JC, Furtado RHM, Silva SA, Rochitte CE, Rassi A Jr, Moraes JBMC Jr, Quintella E, Costantini CR, Korman APM, Mattos MA, Castello HJ Jr, Caixeta A, Dohmann HFR, de Carvalho ACC; MiHeart/AMI Investigators.

Clin Cardiol. 2018 Mar;41(3):392-399. doi: 10.1002/clc.22882. Epub 2018 Mar 22.

30.

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models.

Bezman NA, Jhatakia A, Kearney AY, Brender T, Maurer M, Henning K, Jenkins MR, Rogers AJ, Neeson PJ, Korman AJ, Robbins MD, Graziano RF.

Blood Adv. 2017 May 8;1(12):753-765. doi: 10.1182/bloodadvances.2017004382. eCollection 2017 May 9.

31.

Interleukin-21 combined with PD-1 or CTLA-4 blockade enhances antitumor immunity in mouse tumor models.

Lewis KE, Selby MJ, Masters G, Valle J, Dito G, Curtis WR, Garcia R, Mink KA, Waggie KS, Holdren MS, Grosso JF, Korman AJ, Jure-Kunkel M, Dillon SR.

Oncoimmunology. 2017 Oct 4;7(1):e1377873. doi: 10.1080/2162402X.2017.1377873. eCollection 2017.

32.

Does Digital Rectal Examination Predict Hospital Admission and Resource Utilization Rate in Patients with Acute Gastrointestinal Bleeding with Bright Red Blood Per Rectum?

Charilaou P, Korman A, Pitchumoni CS, Broder A.

Am J Med. 2018 Jan;131(1):e31. doi: 10.1016/j.amjmed.2017.08.008. No abstract available.

PMID:
29224616
33.

Combining intratumoral Treg depletion with androgen deprivation therapy (ADT): preclinical activity in the Myc-CaP model.

Shen YC, Ghasemzadeh A, Kochel CM, Nirschl TR, Francica BJ, Lopez-Bujanda ZA, Carrera Haro MA, Tam A, Anders RA, Selby MJ, Korman AJ, Drake CG.

Prostate Cancer Prostatic Dis. 2018 Apr;21(1):113-125. doi: 10.1038/s41391-017-0013-x. Epub 2017 Dec 4.

34.

CD137 (4-1BB) Costimulation Modifies DNA Methylation in CD8+ T Cell-Relevant Genes.

Aznar MA, Labiano S, Diaz-Lagares A, Molina C, Garasa S, Azpilikueta A, Etxeberria I, Sanchez-Paulete AR, Korman AJ, Esteller M, Sandoval J, Melero I.

Cancer Immunol Res. 2018 Jan;6(1):69-78. doi: 10.1158/2326-6066.CIR-17-0159. Epub 2017 Nov 13.

35.

Conditioned media from the renal cell carcinoma cell line 786.O drives human blood monocytes to a monocytic myeloid-derived suppressor cell phenotype.

Okada SL, Simmons RM, Franke-Welch S, Nguyen TH, Korman AJ, Dillon SR, Gilbertson DG.

Cell Immunol. 2018 Jan;323:49-58. doi: 10.1016/j.cellimm.2017.10.014. Epub 2017 Oct 31.

PMID:
29103587
36.

Novel mouse models of hepatic artery infusion.

Kim M, Fisher DT, Powers CA, Gabriel EM, Korman AM, Sexton S, Gudkov AV, Skitzki JJ.

J Surg Res. 2017 Nov;219:25-32. doi: 10.1016/j.jss.2017.05.083. Epub 2017 Jun 21.

PMID:
29078890
37.

Frequent skin examinations in patients with actinic keratoses: Ethical, financial, and moral implications.

Milam P, Korman A, Kaffenberger J.

J Am Acad Dermatol. 2017 Nov;77(5):985-987. doi: 10.1016/j.jaad.2017.03.005. No abstract available.

PMID:
29029915
38.

Outcomes From U.S. Military-Supported Overseas Training Rotations in Tropical Medicine and Global Health, 2006-2015.

Mancuso JD, Garges EC, Hickey PW, Coldren RL, Korman AK, Keep LW, DeFraites RF, Sanchez JL.

Mil Med. 2017 Sep;182(9):e1796-e1801. doi: 10.7205/MILMED-D-16-00408.

PMID:
28885939
39.

A novel technique for biliary polypectomy.

D'Souza LS, Korman A, Benias PC, Carr-Locke DL.

Endoscopy. 2017 Oct;49(10):E244-E245. doi: 10.1055/s-0043-114408. Epub 2017 Jul 31. No abstract available.

PMID:
28759924
40.

Percutaneous endoscopic necrosectomy.

D'Souza LS, Korman A, Carr-Locke DL, Benias PC.

Endoscopy. 2017 Oct;49(10):E242-E243. doi: 10.1055/s-0043-114407. Epub 2017 Jul 18. No abstract available.

PMID:
28719929
41.

Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab.

Ramagopal UA, Liu W, Garrett-Thomson SC, Bonanno JB, Yan Q, Srinivasan M, Wong SC, Bell A, Mankikar S, Rangan VS, Deshpande S, Korman AJ, Almo SC.

Proc Natl Acad Sci U S A. 2017 May 23;114(21):E4223-E4232. doi: 10.1073/pnas.1617941114. Epub 2017 May 8.

42.

Viral exanthems: An update on laboratory testing of the adult patient.

Korman AM, Alikhan A, Kaffenberger BH.

J Am Acad Dermatol. 2017 Mar;76(3):538-550. doi: 10.1016/j.jaad.2016.08.034. Epub 2016 Oct 26. Review.

PMID:
28413059
43.

Masterful Antibodies: Checkpoint Blockade.

Lonberg N, Korman AJ.

Cancer Immunol Res. 2017 Apr;5(4):275-281. doi: 10.1158/2326-6066.CIR-17-0057. Review.

44.

DoD-Supported Overseas Training Rotations in Tropical Medicine and Global Health, 2000-2015.

Mancuso JD, Hickey PW, Coldren RL, Korman AK, Keep LW, DeFraites RF, Smith M, Mancuso LJ, Sanchez JL.

Mil Med. 2017 Mar;182(3):e1719-e1725. doi: 10.7205/MILMED-D-16-00108.

PMID:
28290949
45.

Radiation recall dermatitis associated with nivolumab for metastatic malignant melanoma.

Korman AM, Tyler KH, Kaffenberger BH.

Int J Dermatol. 2017 Apr;56(4):e75-e77. doi: 10.1111/ijd.13513. Epub 2017 Jan 19. No abstract available.

PMID:
28102540
46.

Temporally Distinct PD-L1 Expression by Tumor and Host Cells Contributes to Immune Escape.

Noguchi T, Ward JP, Gubin MM, Arthur CD, Lee SH, Hundal J, Selby MJ, Graziano RF, Mardis ER, Korman AJ, Schreiber RD.

Cancer Immunol Res. 2017 Feb;5(2):106-117. doi: 10.1158/2326-6066.CIR-16-0391. Epub 2017 Jan 10.

47.

Effective Combination of Innate and Adaptive Immunotherapeutic Approaches in a Mouse Melanoma Model.

Rakhmilevich AL, Felder M, Lever L, Slowinski J, Rasmussen K, Hoefges A, Van De Voort TJ, Loibner H, Korman AJ, Gillies SD, Sondel PM.

J Immunol. 2017 Feb 15;198(4):1575-1584. doi: 10.4049/jimmunol.1601255. Epub 2017 Jan 6.

48.

Individual versus collective cognition in social insects.

Feinerman O, Korman A.

J Exp Biol. 2017 Jan 1;220(Pt 1):73-82. doi: 10.1242/jeb.143891. Review.

49.

Sweet-Like Eruption Associated With Obinutuzumab Therapy for Chronic Lymphocytic Leukemia.

Korman AM, Hastings JG, Byrd JC, Kaffenberger BH.

JAMA Dermatol. 2017 Jan 1;153(1):108-110. doi: 10.1001/jamadermatol.2016.3355. No abstract available.

PMID:
27892987
50.

Correction: Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology.

Selby MJ, Engelhardt JJ, Johnston RJ, Lu LS, Han M, Thudium K, Yao D, Quigley M, Valle J, Wang C, Chen B, Cardarelli PM, Blanset D, Korman AJ.

PLoS One. 2016 Nov 18;11(11):e0167251. doi: 10.1371/journal.pone.0167251. eCollection 2016.

Supplemental Content

Loading ...
Support Center